Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-26 @ 2:56 AM
Study NCT ID:
NCT04711902
Status:
COMPLETED
Last Update Posted:
2024-10-09
First Post:
2021-01-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-24
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-10
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-14
First Submit QC Date:
None
Study First Post Date:
2021-01-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-02-07
Results First Submit QC Date:
None
Results First Post Date:
2024-07-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-04-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-10-09
Last Update Post Date Type:
ACTUAL